Shariat et al., in their study involving 630 patients, have concluded that a correlation between BCR and LVI is mediated via an association with established features of biologically aggressive prostate cancer, and that LVI is a lethal phenotype of prostate cancer, leading to early metastasis and lower overall survival [2]. This evidence concerns the gene BCR and prostate cancer.